TrialFind
Saved trials
Back to results
Completed
Phase 2
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
NCT04508803
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Fudan University Shanghai Cancer center
Shanghai, China
View on ClinicalTrials.gov
Official details
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer — TrialFind